imbruvica - ibrutinib capsule
(Ibrutinib)Pharmacyclics Llc
Usage: IMBRUVICA treats adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), including those with 17p deletion, and Waldenström's macroglobulinemia. It also treats adults and children aged 1 year and older with chronic graft-versus-host disease (cGVHD) after prior systemic therapy has failed.